Somatic mutations in disorders with disrupted brain connectivity

Experimental and Molecular Medicine

Volumn 48, Issue 6, 2016, Pages

  Lee, Jeong Ho ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ANIMAL; AUTISM; BRAIN; BRAIN DISEASE; EPILEPSY; GENE FREQUENCY; GENETICS; HUMAN; MAJOR DEPRESSION; METABOLISM; MUTATION; NERVE CELL; NERVE CELL NETWORK; NERVOUS SYSTEM DEVELOPMENT; PATHOLOGY; PATHOPHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; AUTISTIC DISORDER; BRAIN; BRAIN DISEASES; DEPRESSIVE DISORDER, MAJOR; EPILEPSY; GENE FREQUENCY; HUMANS; MUTATION; NERVE NET; NEUROGENESIS; NEURONS;

EID: 85014334912     PISSN: 12263613     EISSN: 20926413     Source Type: Journal    
DOI: 10.1038/EMM.2016.53     Document Type: Review

References (102)

1. Lynch M. Rate, molecular spectrum, and consequences of human mutation. Proc Natl Acad Sci USA 2010; 107: 961–968.
2. Lupski JR. Genome mosaicism–one human, multiple genomes. Science 2013; 341: 358–359.
3. Biesecker LG, Spinner NB. A genomic view of mosaicism and human disease. Nat Rev Genet 2013; 14: 307–320.
4. Campbell IM, Shaw CA, Stankiewicz P, Lupski JR. Somatic mosaicism: implications for disease and transmission genetics. Trends Genet 2015; 31: 382–392.
5. Insel TR. Brain somatic mutations: the dark matter of psychiatric genetics? Mol Psychiatry 2014; 19: 156–158.
6. Sanai N, Nguyen T, Ihrie RA, Mirzadeh Z, Tsai H-H, Wong M et al. Corridors of migrating neurons in the human brain and their decline during infancy. Nature 2011; 478: 382–386.
7. Eriksson PS, Perfilieva E, Björk-Eriksson T, Alborn A-M, Nordborg C, Peterson DA et al. Neurogenesis in the adult human hippocampus. Nat Med 1998; 4: 1313–1317.
8. Ernst A, Alkass K, Bernard S, Salehpour M, Perl S, Tisdale J et al. Neurogenesis in the striatum of the adult human brain. Cell 2014; 156: 1072–1083.
9. Spalding KL, Bergmann O, Alkass K, Bernard S, Salehpour M, Huttner HB et al. Dynamics of hippocampal neurogenesis in adult humans. Cell 2013; 153: 1219–1227.
10. Sanai N, Tramontin AD, Quiñones-Hinojosa A, Barbaro NM, Gupta N, Kunwar S et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nat Cell Biol 2004; 427: 740–744.
11. Cai X, Evrony GD, Lehmann HS, Elhosary PC, Mehta BK, Poduri A et al. Single-cell, genome-wide sequencing identifies clonal somatic copy-number variation in the human brain. Cell Rep 2014; 8: 1280–1289.
12. McConnell MJ, Lindberg MR, Brennand KJ, Piper JC, Voet T, Cowing-Zitron C et al. Mosaic copy number variation in human neurons. Science 2013; 342: 632–637.
13. Williams SL, Mash DC, Züchner S, Moraes CT. Somatic mtDNA mutation spectra in the aging human putamen. PLoS Genet 2013; 9: e1003990.
14. Evrony GD, Lee E, Mehta BK, Benjamini Y. Cell lineage analysis in human brain using endogenous retroelements. Neuron 2015; 85: 49–59.
15. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA, Kinzler KW. Cancer genome landscapes. Science 2013; 339: 1546–1558.
16. Fornito A, Zalesky A, Breakspear M. The connectomics of brain disorders. Nat Rev Neurosci 2015; 16: 159–172.
17. Sporns O, Tononi G, Kötter R. The human connectome: a structural description of the human brain. PLOS Comput Biol 2005; 1: e42.
18. Buldyrev SV, Parshani R, Paul G, Stanley HE, Havlin S. Catastrophic cascade of failures in interdependent networks. Nature 2010; 464: 1025–1028.
19. Engel J Jr, Thompson PM, Stern JM, Staba RJ, Bragin A, Mody I et al. Connectomics and epilepsy. Curr Opin Neurobiol 2013; 26: 186–194.
20. Fornito A, Bullmore ET. Connectomic intermediate phenotypes for psychiatric disorders. Front Psychiatry 2012; 3: 32.
21. Hahamy A, Behrmann M, Malach R. The idiosyncratic brain: distortion of spontaneous connectivity patterns in autism spectrum disorder. Nat Neurosci 2015; 18: 302–309.
22. Matthews PM, Filippini N, Douaud G. Brain structural and functional connectivity and the progression of neuropathology in Alzheimer's disease. J Alzheimers Dis 2013; 33(Suppl 1): S163–S172.
23. Narr KL. Leaver AM. connectome and schizophrenia. Curr Opin Psychiatry 2015; 28: 229–235.
24. Peled A. Brain ‘Globalopathies’ cause mental disorders. Med Hypothese 2013; 81: 1046–1055.
25. Toga AW, Thompson PM. Connectopathy in ageing and dementia. Brain 2014; 137: 3104–3106.
26. Seung S. Coonectome: How the Brain's Wiring Makes Us Who We Are. Houghton Mifflin Harcourt: New York, USA, 2012.
27. Speed D, O'Brien TJ, Palotie A, Shkura K, Marson AG, Balding DJ et al. Describing the genetic architecture of epilepsy through heritability analysis. Brain 2014; 137: 2680–2689.
28. Abrahams BS, Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nat Rev Genet 2008; 9: 341–355.
29. Cannon TD, Kaprio J, Lonnqvist J, Huttunen M, Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort—A population-based modeling study. Archives Gen Psychiatry 1998; 55: 67–74.
30. Sullivan PF, Neale MC, Kendler KS. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiatry 2000; 157: 1552–1562.
31. Gatz M, Pedersen NL, Berg S, Johansson B, Johansson K, Mortimer JA et al. Heritability for Alzheimer's disease: the study of dementia in Swedish twins. J Gerontol A Biol Sci Med Sci 1997; 52A: M117–M125.
32. Gauthier J, Rouleau GA. De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention. Genome Med 2012; 4: 71.
33. Veltman JA, Brunner HG. De novo mutations in human genetic disease. Nat Rev Genet 2012; 13: 565–575.
34. Consortium E, Project EPG, De novo mutations in epileptic encephalopathies. Nature 2013; 501: 1–7.
35. Iossifov I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 2014; 515: 216–221.
36. Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 2014; 506: 179–184.
37. Krumm N, O'Roak BJ, Shendure J, Eichler EE. A de novo convergence of autism genetics and molecular neuroscience. Trends Neurosci 2014; 37: 95–105.
38. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012; 485: 246–U136.
39. Bin Xu, Roos JL, Levy S, Van Rensburg EJ, Gogos JA, Karayiorgou M. Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 2008; 40: 880–885.
40. Ryvlin P, Cross JH, Rheims S. Epilepsy surgery in children and adults. Lancet Neurol 2014; 13: 1114–1126.
41. Briellmann RS, Jackson GD, Torn Broers Y, Berkovic SF. Causes of epilepsies: insights from discordant monozygous twins. Ann Neurol 2001; 49: 45–52.
42. Crino PB. Focal brain malformations: seizures, signaling, sequencing. Epilepsia 2009; 50(Suppl 9): 3–8.
43. Lee JH, Huynh M, Silhavy JL, Kim S, Dixon-Salazar T, Heiberg A et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012; 44: 941–945.
44. Poduri A, Evrony GD, Cai X, Elhosary PC, Beroukhim R, Lehtinen MK et al. Somatic activation of AKT3 causes hemispheric developmental brain malformations. Neuron 2012; 74: 41–48.
45. Rivière J-B, Mirzaa GM, O'Roak BJ, Beddaoui M, Alcantara D, Conway RL et al. De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 2012; 44: 934–940.
46. D’Gama AM, Geng Y, Couto JA, Martin B, Boyle EA, LaCoursiere CM et al. Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia. Ann Neurol 2015; 77: 720–725.
47. Jansen LA, Mirzaa GM, Ishak GE, O'Roak BJ, Hiatt JB, Roden WH et al. PI3K/AKT pathway mutations cause a spectrum of brain malformations from megalencephaly to focal cortical dysplasia. Brain 2015; 138: 1613–1628.
48. Lim JS, Kim W-I, Kang H-C, Kim SH, Park AH, Park EK et al. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy. Nat Med 2015; 21: 395–400.
49. Nakashima M, Saitsu H, Takei N, Tohyama J, Kato M, Kitaura H et al. Somatic mutations in the MTOR gene cause focal cortical dysplasia type IIb. Ann Neurol 2015; 78: 375–386.
50. Di Martino A, Yan CG, Li Q, Denio E, Castellanos FX, Alaerts K et al. The autism brain imaging data exchange: towards a large-scale evaluation of the intrinsic brain architecture in autism. Mol Psychiatry 2014; 19: 659–667.
51. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Krumm N, Coe BP et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012; 485: 246–250.
52. Neale BM, Kou Y, Liu L, Ma'ayan A, Samocha KE, Sabo A et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012; 485: 242–U129.
53. Valk SL, Di Martino A, Milham MP, Bernhardt BC. Multicenter mapping of structural network alterations in autism. Hum Brain Mapp 2015; 36: 2364–2373.
54. Casanova MF, El-Baz AS, Kamat SS, Dombroski BA, Khalifa F, Elnakib A et al. Focal cortical dysplasias in autism spectrum disorders. Acta Neuropathol Commun 2013; 1: 67.
55. Stoner R, Chow ML, Boyle MP, Sunkin SM, Mouton PR, Roy S et al. Patches of disorganization in the neocortex of children with autism. N Engl J Med 2014; 370: 1209–1219.
56. Wegiel J, Kuchna I, Nowicki K, Imaki H, Wegiel J, Marchi E et al. The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes. Acta Neuropathol 2010; 119: 755–770.
57. D’Gama AM, Pochareddy S, Li M, Jamuar SS, Reiff RE, Lam A-TN et al. Targeted DNA sequencing from autism spectrum disorder brains implicates multiple genetic mechanisms. Neuron 2015; 88: 910–917.
58. Sequeira A, Martin MV, Rollins B, Moon EA, Bunney WE, Macciardi F et al. Mitochondrial mutations and polymorphisms in psychiatric disorders. Front Gene 2012; 3: 103.
59. Kato T, Iwamoto K, Kakiuchi C, Kuratomi G, Okazaki Y. Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders. Mol Psychiatry 2005; 10: 622–630.
60. Consortium C. Sparse whole-genome sequencing identifies two loci for major depressive disorder. Nature 2015; 523: 588–591.
61. Consortium SWGOTPG. Biological insights from 108 schizophrenia-associated genetic loci. Nature 2014; 511: 421–427.
62. Dempster EL, Pidsley R, Schalkwyk LC, Owens S, Georgiades A, Kane F et al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum Mol Gen 2011; 20: 4786–4796.
63. MacDonald AW III, Carter CS, Kerns JG. Specificity of prefrontal dysfunction and context processing deficits to schizophrenia in never-medicated patients with first-episode psychosis. Am J Psychiatry 2005; 162: 475–484.
64. Murray EA, Wise SP, Drevets WC. Localization of dysfunction in major depressive disorder: prefrontal cortex and amygdala. Biol Psychiatry 2011; 69: e43–e45.
65. Bundo M, Toyoshima M, Okada Y, Akamatsu W, Ueda J, Nemoto-Miyauchi T et al. Increased L1 retrotransposition in the neuronal genome in schizophrenia. Neuron 2014; 81: 306–313.
66. Kim J, Shin J-Y, Kim J-I, Seo J-S, Webster MJ, Lee D et al. Somatic deletions implicated in functional diversity of brain cells of individuals with schizophrenia and unaffected controls. Sci Rep 2014; 4: 3807.
67. Loy CT, Schofield PR, Turner AM, Kwok JB. Genetics of dementia. Lancet 2014; 383: 828–840.
68. Pamphlett R. The ‘somatic-spread’ hypothesis for sporadic neurodegen-erative diseases. Med Hypothese 2011; 77: 544–547.
69. Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. Neuropathological alterations in alzheimer disease. Cold Spring Harb Perspect Med 2011; 1: a006189–a006189.
70. Brundin P, Melki R, Kopito R. Prion-like transmission of protein aggregates in neurodegenerative diseases. Nat Rev Mol Cell Biol 2010; 11: 301–307.
71. Frigerio CS, Lau P, Troakes C, Deramecourt V, Gele P, Van Loo P et al. On the identification of low allele frequency mosaic mutations in the brains of Alzheimer disease patients. Alzheimers Dement 2015; 11: 1265–1276.
72. Parcerisas A, Rubio SE, Muhaisen A, Gómez-Ramos A, Pujadas L, Puiggros M et al. Somatic signature of brain-specific single nucleotide variations in sporadic Alzheimer's disease. J Alzheimers Dis 2014; 42: 1357–1382.
73. Jamuar SS, Lam A-TN, Kircher M, D’Gama AM, Wang J, Barry BJ et al. Somatic mutations in cerebral cortical malformations. N Engl J Med 2014; 371: 733–743.
74. Shirley MD, Tang H, Gallione CJ, Baugher JD, Frelin LP, Cohen B et al. Sturge–Weber Syndrome and Port-Wine Stains caused by somatic mutation in GNAQ. N Engl J Med 2013; 368: 1971–1979.
75. Schirmer M, Ijaz UZ, D'Amore R, Hall N, Sloan WT, Quince C. Insight into biases and sequencing errors for amplicon sequencing with the Illumina MiSeq platform. Nucleic Acids Res 2015; 43: e37.
76. Costello M, Pugh TJ, Fennell TJ, Stewart C, Lichtenstein L, Meldrim JC et al. Discovery and characterization of artifactual mutations in deep coverage targeted capture sequencing data due to oxidative DNA damage during sample preparation. Nucleic Acids Res 2013; 41: e67–e67.
77. GLENN TC. Field guide to next‐generation DNA sequencers. Mol Ecol Resour 2011; 11: 759–769.
78. Robasky K, Lewis NE, Church GM. The role of replicates for error mitigation in next-generation sequencing. Nat Rev Genet 2013; 15: 56–62.
79. Shapiro E, Biezuner T, Linnarsson S. Single-cell sequencing-based technologies will revolutionize whole-organism science. Nat Rev Genet 2013; 14: 618–630.
80. de Bourcy CFA, De Vlaminck I, Kanbar JN, Wang J, Gawad C, Quake SR. A quantitative comparison of single-cell whole genome amplification methods. PLoS ONE 2014; 9: e105585.
81. Voet T, Van Loo P. SNES makes sense? Single-cell exome sequencing evolves. Genome Biol 2015; 16: 86.
82. Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, Sougnez C et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 2013; 31: 213–219.
83. Kim S, Jeong K, Bhutani K, Lee J, Patel A, Scott E et al. Virmid: accurate detection of somatic mutations with sample impurity inference. Genome Biol 2013; 14: R90.
84. Saunders CT, Wong WSW, Swamy S, Becq J, Murray LJ, Cheetham RK. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 2012; 28: 1811–1817.
85. Xu H, DiCarlo J, Satya RV, Peng Q, Wang Y. Comparison of somatic mutation calling methods in amplicon and whole exome sequence data. BMC Genomics 2014; 15: 1.
86. Kim J, Kim S, Nam H, Kim S, Lee D. SoloDel: a probabilistic model for detecting low-frequent somatic deletions from unmatched sequencing data. Bioinformatics 2015; 31: btv358–3113.
87. Wilm A, Aw PPK, Bertrand D, Yeo GHT, Ong SH, Wong CH et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res 2012; 40: gks918–11201.
88. Kim H, Kim J-S. A guide to genome engineering with programmable nucleases. Nat Rev Genet 2014; 15: 321–334.
89. Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol 2014; 32: 347–355.
90. Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell 2014; 157: 1262–1278.
91. Wang T, Wei JJ, Sabatini DM, Lander ES. Genetic screens in human cells using the CRISPR/Cas9 system. Science 2014; 343: 80–84.
92. Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 2014; 343: 84–87.
93. Sánchez-Rivera FJ, Papagiannakopoulos T, Romero R, Tammela T, Bauer MR, Bhutkar A et al. Rapid modelling of cooperating genetic events in cancer through somatic genome editing. Nature 2014; 516: 428–431.
94. Xue W, Chen S, Yin H, Tammela T, Papagiannakopoulos T, Joshi NS et al. CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature 2000; 514: 380–384.
95. Swiech L, Heidenreich M, Banerjee A, Habib N, Li Y, Trombetta J et al. In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol 2015; 33: 102–106.
96. Zuckermann M, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Schramm K et al. Somatic CRISPR/Cas9-mediated tumour suppressor disruption enables versatile brain tumour modelling. Nat Commun 2015; 6: 7391.
97. Babiloni F, Cincotti F, Babiloni C, Carducci F, Mattia D, Astolfi L et al. Estimation of the cortical functional connectivity with the multimodal integration of high-resolution EEG and fMRI data by directed transfer function. Neuroimage 2005; 24: 118–131.
98. Guye M, Bartolomei F, Ranjeva J-P. Imaging structural and functional connectivity: towards a unified definition of human brain organization? Curr Opin Neurobiol 2008; 21: 393–403.
99. Einevoll GT, Franke F, Hagen E, Pouzat C, Harris KD. Towards reliable spike-train recordings from thousands of neurons with multielectrodes. Curr Opin Neurobiol 2012; 22: 11–17.
100. Oh SW, Harris JA, Ng L, Winslow B, Cain N, Mihalas S et al. A mesoscale connectome of the mouse brain. Nature 2014; 508: 207–214.
101. Stosiek C, Garaschuk O, Holthoff K, Konnerth A. In vivo two-photon calcium imaging of neuronal networks. Proc Natl Acad Sci USA 2003; 100: 7319–7324.
102. Mikula S, Denk W. High-resolution whole-brain staining for electron microscopic circuit reconstruction. Nat Methods 2015; 12: 541–546.